Dr. Xueyang Yu is a postdoctoral fellow working in the laboratory of Dr. Michael B. Yaffe at Koch Institute for Integrative Cancer Research at MIT, Cambridge. She obtained her master degree in Molecular and Cellular Biology at Heidelberg University in Germany, and her Ph.D. at the Institute of Experimental Immunology at University of Zurich in Switzerland. During her Ph.D. training, Dr. Yu focused on the interplay of tissue microenvironment and macrophage heterogeneity. Her Ph.D. thesis work on the role of transforming growth factor beta (TGF-β) in the development and homeostasis of tissue-resident macrophages, became a landmark discovery in field of myeloid cell biology. With her expertise in innate immunology, Dr. Yu joined Dr. Michael B. Yaffe’s group, who has a long history of studying stress signaling and pathway cross-talk in cancer. Dr. Yu is aimed at discovering the role of stress pathways in controlling macrophage-regulated tumor microenvironment during ovarian cancer progression.